Kite Pharma Inc (KITE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KITE | SRPT | EXEL | ||
| Company | Kite Pharma Inc | Sarepta Therapeutics | Exelixis Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 179.99 | 110.68 | 34.83 | ||
| High | 179.99 | 114.83 | 35.69 | ||
| Low | 179.99 | 110.50 | 34.76 | ||
| Last | 179.99 | 114.23 | 35.61 | ||
| Change | +0.20 | +3.73 | +0.78 | ||
| % Change | +0.11% | +3.38% | +2.24% | ||
| Volume | 100 | 913,700 | 1,763,900 | ||
| 20-Day Average Volume | 2,576,370 | 1,104,025 | 2,642,155 | ||
| Previous Close | 179.79 | 110.50 | 34.83 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 179.18 | 118.04 | 34.22 | ||
| 20-Day Raw Stochastic | 100.00% | 39.15% | 88.42% | ||
| 20-Day Relative Strength | 86.68% | 43.09% | 72.14% | ||
| Weighted Alpha | +211.40 | +6.09 | +76.78 | ||
| Today's Opinion | N/A | 88% Sell | 100% Buy | ||
| Previous Opinion | N/A | 88% Sell | 100% Buy | ||
| Last Month's Opinion | N/A | 24% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.19% since 09/26/17 | +9.27% since 11/15/24 | +3.37% since 11/15/24 | ||
| Low | 179.55 on 10/02/17 | 102.15 on 11/18/24 | 33.82 on 11/19/24 | ||
| High | 179.99 on 10/03/17 | 114.83 on 11/22/24 | 35.69 on 11/22/24 | ||
| 1-Month | |||||
| %Chg | +1.09% since 09/01/17 | -11.05% since 10/22/24 | +23.52% since 10/22/24 | ||
| Low | 177.65 on 09/05/17 | 102.15 on 11/18/24 | 27.86 on 10/25/24 | ||
| High | 179.99 on 10/03/17 | 133.36 on 10/25/24 | 36.60 on 11/08/24 | ||
| 3-Month | |||||
| %Chg | +72.35% since 07/03/17 | -19.23% since 08/22/24 | +38.13% since 08/22/24 | ||
| Low | 100.09 on 07/10/17 | 102.15 on 11/18/24 | 25.12 on 09/09/24 | ||
| High | 179.99 on 10/03/17 | 143.49 on 08/23/24 | 36.60 on 11/08/24 | ||
| 6-Month | |||||
| %Chg | +130.11% since 04/03/17 | -10.97% since 05/22/24 | +69.57% since 05/22/24 | ||
| Low | 66.75 on 05/09/17 | 102.15 on 11/18/24 | 20.14 on 05/29/24 | ||
| High | 179.99 on 10/03/17 | 173.25 on 06/21/24 | 36.60 on 11/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,314,552 | 10,911,249 | 10,169,469 | ||
| Shares Outstanding, K | 57,370 | 95,520 | 285,579 | ||
| Annual Sales | 22,170,000 | 1,243,340,000 | 1,830,210,000 | ||
| Annual Net Income | -267,070,000 | -535,980,000 | 207,770,000 | ||
| Last Quarter Sales | 10,050,000 | 467,170,000 | 539,540,000 | ||
| Last Quarter Net Income | -109,820,000 | 33,610,000 | 117,970,000 | ||
| 60-Month Beta | 2.68 | 0.81 | 0.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.50 on 08/08/17 | 0.62 on 11/06/24 | 0.47 on 10/29/24 | ||
| Latest Earnings Date | 11/08/17 | 11/06/24 | 10/29/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 95.26 | 22.62 | ||